Wutah dodolan YoY sajrone 12 wulan kepungkur: Replimune Group, Inc. (REPL)

Logo perusahaan publik Replimune Inc. (REPL)

Innovative oncolytic viruses based on its own R&D platform have become the growth driver for Replimune Group, Inc. (REPL). The year-over-year (TTM) commercial revenue growth trend visualizes this progress, where the 0.00 metric reflects the current dynamics. Strategic alliances with pharma behemoths have strengthened its scientific potential, while the anticipation of Phase 3 melanoma results and FDA approval, despite priced-in losses, creates a positive backdrop.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Replimune (REPL): kanggo periode 11.02.2024 - 16.11.2026

Replimune (REPL) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
Ringkesan analitik perusahaan:Replimune Group, Inc.
Sampel barang replimune.com

To assess the fundamental stability of an asset, an investor must analyze business scaling dynamics via the rolling annual revenue growth rate. This year-over-year sales trajectory (TTM) measures operational expansion, allowing growth rates to be correlated with the commercialization potential of the RP1 drug and the prospects of Replimune Group, Inc. (REPL) being acquired by pharmaceutical behemoths following FDA approval.

Pesaing Replimune Group, Inc. (REPL)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur LYEL|innate-pharma.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Pyxis Oncology|Compugen Limited (CGEN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|IO Biotech, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|STRO (sutrobio.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) MiNK Therapeutics Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur werewolftx.com (HOWL)|IMMX: Wutah dodolan taun lumaku|alxoncology.com - Wutah pendapatan YoY sajrone 12 wulan kepungkur|CUE - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PDSB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Sonnet BioTherapeutics Holdings SONN|MAIA: Wutah dodolan YoY (TTM)|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur